In non-small cell lung cancer, high expression of A1AT in plasma suggests that it is related to the poor prognosis of patients, and increased SERPINA1 in cell experiments has been shown to promote the proliferation and migration of lung cancer cells and inhibit apoptosis [20]. Here, SERPINA1 is linked to non-small cell lung carcinoma.